Academic partner
of Lymphoma
Clinical Research

Early Phase Clinical Trials Platform: EARLY

EARLY platform combines the skills of the LYSARC dedicated team and the LYSA experts center network to conduct early phase lymphoma trials.

The LYSA center network includes early-phase centers (“CLIP2″) accredited by the French National Cancer Institute (INCa).


This platform for the realization of phase I/IIa clinical trials, in cooperation with industry. conducts:

• first-in man studies,

• first-in-lymphoma studies,

• first combo studies.

About twelve LYSA centers are available for phase I trials and more than thirty LYSA centers for phase II trials.

LYSARC has a large experience in lymphoma early clinical development with more than 40 trials so far.

Please, download our EARLY LYSA-LYSARC Platform leaflet!